Bain Capital Life Sciences Investors, LLC - Insider Trading & Ownership

Entity: Company
Location: 200 Clarendon Street, Boston, MA
Summary: The estimated value of insider holdings of Bain Capital Life Sciences Investors, LLC is at least $457M dollars as of February 14, 2024. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $201M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $199M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Annexon, Inc. and owns shares of Annexon, Inc. (ANNX) stock worth about $24.4M. Bain Capital Life Sciences Investors, LLC is the Director, 10%+ Owner of Solid Biosciences Inc. and owns shares of Solid Biosciences Inc. (SLDB) stock worth about $22.3M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of RAPID MICRO BIOSYSTEMS, INC. and owns shares of RAPID MICRO BIOSYSTEMS, INC. (RPID) stock worth about $8.35M. Bain Capital Life Sciences Investors, LLC is the 10%+ Owner of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $2.33M.
All Insider Reports: All Insider Reports

Ownership of Bain Capital Life Sciences Investors, LLC

Symbol	Company	Relationship	Holdings Value	Report Period
SWTX	SpringWorks Therapeutics, Inc.	10%+ Owner	$201M	Aug 10, 2021
NAMS, NAMSW	NewAmsterdam Pharma Co N.V.	10%+ Owner	$199M	Dec 29, 2023
ANNX	Annexon, Inc.	10%+ Owner	$24.4M	May 25, 2023
SLDB	Solid Biosciences Inc.	Director, 10%+ Owner	$22.3M	Jan 11, 2024
RPID	RAPID MICRO BIOSYSTEMS, INC.	10%+ Owner	$8.35M	Jul 19, 2021
XLO	Xilio Therapeutics, Inc.	10%+ Owner	$2.33M	Dec 8, 2021
KYTX	Kyverna Therapeutics, Inc.	10%+ Owner		Feb 12, 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.